Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders)
  4. Volume 25, Issue 1
  5. Article
Volume 25, Issue 1
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

There is no abstract available.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265299597240422102455
2024-04-29
2025-01-11

  • From This Site

    /content/journals/iddt/10.2174/0118715265299597240422102455
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/iddt/25/1/IDDT-25-1-05.html?itemId=/content/journals/iddt/10.2174/0118715265299597240422102455&mimeType=html&fmt=ahah

References

  1. El-ArifG. KhazaalS. FarhatA. Angiotensin II type I receptor (AT1R): The gate towards COVID-19-associated diseases.Molecules2022277204810.3390/molecules27072048 35408447
     [Google Scholar]
  2. CapuanoC. De FedericisD. CiutiD. Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in natural killer cells: Relevance for antibody-dependent functions.Front. Immunol.202314128520310.3389/fimmu.2023.1285203
     [Google Scholar]
  3. de QueirozT.M. LakkappaN. LazartiguesE. ADAM17-mediated shedding of inflammatory cytokines in hypertension.Front. Pharmacol.202011115410.3389/fphar.2020.01154 32848763
     [Google Scholar]
  4. RomeeR. FoleyB. LenvikT. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17).Blood2013121183599360810.1182/blood‑2012‑04‑425397 23487023
     [Google Scholar]
  5. EdwardsD. HandsleyM. PenningtonC. The ADAM metalloproteinases.Mol. Aspects Med.200829525828910.1016/j.mam.2008.08.001 18762209
     [Google Scholar]
  6. TsakadzeN.L. SithuS.D. SenU. EnglishW.R. MurphyG. D’SouzaS.E. Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1).J. Biol. Chem.200628163157316410.1074/jbc.M510797200 16332693
     [Google Scholar]
  7. WangK. XuanZ. LiuX. ZhengM. YangC. WangH. Immunomodulatory role of metalloproteinase ADAM17 in tumor development.Front. Immunol.202213105937610.3389/fimmu.2022.1059376 36466812
     [Google Scholar]
  8. GonçalvesJ. SantosC.D. FrescoP. Fernandez-LlimosF. Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity.Rev. Port. Cardiol.202342437338310.1016/j.repc.2022.02.014 36893838
     [Google Scholar]
  9. CaoZ. WuY. FauconE. SabatierJ-M. SARS-CoV-2 & COVID-19: Key-roles of the ‘renin-angiotensin’ system/vitamin D impacting drug and vaccine developments.Infect. Disord. Drug Targets202020334834910.2174/1871526520999200505174704 32370727
     [Google Scholar]
  10. LeclercP.C. ProulxC.D. ArguinG. Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II.Am. J. Hypertens.2008211677110.1038/ajh.2007.1
     [Google Scholar]
/content/journals/iddt/10.2174/0118715265299597240422102455
Loading

  • Article Type:     Editorial
Keyword(s): ACE2; ADAM17; AT1R; COVID-19; SARS-CoV-2; spike

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test